Rasagiline - NDC Database


10 records found:

Sorted by NDC Code

Page of 1
0093-3060 Jan 03, 2017
Rasagiline .5 mg Oral Tablet by Teva Pharmaceuticals USA, Inc.
0093-3061 Jan 03, 2017
Rasagiline 1 mg Oral Tablet by Teva Pharmaceuticals USA, Inc.
16714-770 Apr 17, 2018
Rasagiline .5 mg Oral Tablet by Northstar Rxllc
16714-771 Apr 17, 2018
Rasagiline 1 mg Oral Tablet by Northstar Rxllc
42571-220 Apr 03, 2019
Rasagiline .5 mg Oral Tablet by Micro Labs Limited
42571-221 Apr 03, 2019
Rasagiline 1 mg Oral Tablet by Micro Labs Limited
47781-683 Jan 01, 2017
Rasagiline .5 mg Oral Tablet by Alvogen, Inc.
47781-690 Jan 01, 2017
Rasagiline 1 mg Oral Tablet by Alvogen, Inc.
67877-259 Oct 30, 2017
Rasagiline .5 mg Oral Tablet by Ascend Laboratories, LLC
67877-260 Oct 30, 2017
Rasagiline 1 mg Oral Tablet by Ascend Laboratories, LLC

Notice: The MedsChat® NDC Database compiles publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.


Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 19 September 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA